Forbes published an article on September 25, 2017, entitled, “Groupon Cofounder’s New Healthcare Startup Raises $70 Million In Latest Funding Round”. This article was about Eric Lefkofsky, the co-founder of Tempus.
Forbes reported that Tempus has raised a total of $130 million since 2015.
Tempus is a tech company that focuses on raising money for genomic sequencing for cancer treatments. The program from Tempus will help doctors customize cancer treatments to benefit the individual patient. Recently, they raised $70 million from investors such as New Enterprise Associates and Revolution. Forbes also reports that Lefkofsky and co-founder Brad Keywell have both personally invested in each one of their fundraising efforts for Tempus.
Eric Lefkofsky has had a long career in the tech industry.
He is originally from Southfield, Michigan and he attended school at the University of Michigan. Even though his first job was selling carpet, he would go on to be an entrepreneur and philanthropist. He is the co-founder of Groupon, which is reported by Forbes to be the fastest growing company in history. Lefkofsky also enjoys a successful teaching career in Chicago, where he has taught courses in technology and business. At this time, he teaches mostly at the University of Chicago Booth School of Business. He is also the chairman of Groupon. He has co-founded several other companies during the span of his career.
Lefkofsky is the CEO of Tempus.
Dismayed at the traditional methods of data collection in the treatment of cancer, Eric Lefkofsky co-founded Tempus with a passion to help those battling cancer. Tempus provides a more organized method for doctors to care for their patients.